Non-specific Response to H1N1 Vaccine
This is a prospective observational study with recruitment of healthy volunteers from consecutive recipients of H1N1 influenza vaccine at the University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia.
The purpose of this study is to evaluate certain safety aspects of adjuvanted influenza H1N1 vaccines.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Enhanced Non-Specific T Lymphocytes Response to Influenza A (H1N1) AS03-Adjuvanted Vaccine|
- T Cell Immune responce monitoring after Influenza A (H1N1) AS03-Adjuvanted Vaccination [ Time Frame: At 3 weeks after vaccination ] [ Designated as safety issue: Yes ]
- T Cell Immune responce monitoring after Influenza A (H1N1) AS03-Adjuvanted Vaccination [ Time Frame: At 11 weeks after vaccination. ] [ Designated as safety issue: Yes ]
|Study Start Date:||November 2009|
|Healthy volunteers from recipients of H1N1 vaccine|
Please refer to this study by its ClinicalTrials.gov identifier: NCT01178918
|University Clinic of Respiratory and Allergic Diseases|
|Golnik, Slovenia, 4204|